IceCure Medical Ltd. (ICCM) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Icecure Medical Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.803 -- 00:00:04.366 Good morning, and thank you for standing by. 00:00:04.366 -- 00:00:08.251 Currently, all of the participants are in listen-only mode. 00:00:08.251 -- 00:00:12.377 After management's discussion, there will be a question-and-answer session. 00:00:12.377 -- 00:00:16.201 Please be advised that today's conference call is being recorded. 00:00:16.201 -- 00:00:20.427 I would now like to turn the conference over to Michael Polyview. 00:00:20.427 -- 00:00:21.749 Please go ahead. 00:00:21.749 -- 00:00:25.814 Thank you, Hila, and welcome to Iceture Medical's conference call to review the initial 00:00:25.814 -- 00:00:30.282 results as of and for the 12-month end of December 31, 2025, 00:00:30.282 -- 00:00:33.366 and provide an update on recent operational highlights. 00:00:33.366 -- 00:00:37.071 You may refer to the earnings press release that we issued earlier this morning. 00:00:37.071 -- 00:00:41.116 Participating on today's call is iCertio Medical CEO, Eyal Shamir. 00:00:41.116 -- 00:00:46.523 The company's CP Sales North America, Shadgood, is not able to join due to connectivity 00:00:46.523 -- 00:00:49.347 issues, so I will read his prepared statement. 00:00:49.347 -- 00:00:54.353 Jay LeVay, the company's COO, will be available during the Q&A portion of the 00:00:54.353 -- 00:00:58.416 call. Before we begin, I'll now take a moment to read a statement about federal liquor 00:00:58.416 -- 00:01:02.202 statements. The call and the question and answer section follows the contained federal 00:01:02.202 -- 00:01:06.929 liquor statements within the meaning of the safe harbor provisions of the private securities 00:01:06.929 -- 00:01:11.977 litigation and reform act of 1995 and other federal securities laws. 00:01:11.977 -- 00:01:16.885 Words s...